Enveric Biosciences Expands IP Portfolio with New U.S. Patent Issued for Methods of Treating Psychiatric Disorders

Go back to Enveric Biosciences Expands IP Portfolio with New U.S. Patent Issued for Methods of Treating Psychiatric Disorders
(NASDAQ: ENVB) Delayed: 1.32 -0.02 (1.49%)
Previous Close $1.34    52 Week High
Open $1.31    52 Week Low
Day High $1.34    P/E N/A 
Day Low $1.25    EPS
Volume 118,060